These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 6266253
1. Improved monitoring of gestational trophoblastic neoplasia using a highly sensitive assay for urinary human chorionic gonadotropin. Wehmann RE, Ayala AR, Birken S, Canfield RE, Nisula BC. Am J Obstet Gynecol; 1981 Aug 01; 140(7):753-7. PubMed ID: 6266253 [Abstract] [Full Text] [Related]
2. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease]. Grinevich IuA, Tatarinov IuS, Iugrinova LG, Olefirenko GA, Dotsenko IuS. Vopr Onkol; 1981 Aug 01; 27(12):19-23. PubMed ID: 6275607 [Abstract] [Full Text] [Related]
3. Criteria of complete remission from trophoblastic neoplasia with the use of human chorionic gonadotropin (HCG) excretion pattern as a parameter. Tomoda Y, Asai Y, Arii Y, Kaseki S, Nishi H, Miwa T, Saiki N, Ishizuka N. Cancer; 1977 Sep 01; 40(3):1016-25. PubMed ID: 198083 [Abstract] [Full Text] [Related]
4. [Detection of hCG production in trophoblastic diseases by HCG beta carboxyl-terminal peptide]. Shimizu T, Matsuura S, Mochizuki M. Nihon Sanka Fujinka Gakkai Zasshi; 1983 Oct 01; 35(10):1759-66. PubMed ID: 6195275 [Abstract] [Full Text] [Related]
5. Human chorionic gonadotropin (hCG) beta-core fragment is produced by degradation of hCG or free hCG beta in gestational trophoblastic tumors: a possible marker for early detection of persistent postmolar gestational trophoblastic disease. Okamoto T, Matsuo K, Niu R, Osawa M, Suzuki H. J Endocrinol; 2001 Dec 01; 171(3):435-43. PubMed ID: 11739009 [Abstract] [Full Text] [Related]
6. Monoclonal versus polyclonal antibody radioimmunoassay against the beta-subunit of human chorionic gonadotropin in patients with gestational trophoblastic neoplasia. Wu T, Ballon SC, Teng NN. Am J Obstet Gynecol; 1983 Dec 01; 147(7):821-5. PubMed ID: 6196974 [Abstract] [Full Text] [Related]
7. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin. Than GN, Csaba IF, Bohn H, Szabó DG, Szalmásy M, Menczer G. Oncodev Biol Med; 1982 Dec 01; 3(4):315-23. PubMed ID: 6291007 [Abstract] [Full Text] [Related]
11. Cancer chemotherapy based on the measurement of a tumor specific antigen. Goldstein DP, Nudemberg F, Shirley RL. Surg Forum; 1971 Oct 01; 22():390-2. PubMed ID: 4330603 [No Abstract] [Full Text] [Related]
13. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases. Cole LA, Shahabi S, Butler SA, Mitchell H, Newlands ES, Behrman HR, Verrill HL. Clin Chem; 2001 Feb 01; 47(2):308-15. PubMed ID: 11159780 [Abstract] [Full Text] [Related]
15. Change in human chorionic gonadotropin in gestational trophoblastic disease observed during the course of chemotherapy. Huang SC, Hsieh CY, Ouyang PC. J Formos Med Assoc; 1991 Jan 01; 90(1):53-8. PubMed ID: 1679110 [Abstract] [Full Text] [Related]
16. Concentrations of SP1 and beta-hCG in serum and cerebrospinal fluid and concentrations of hCG in urine in patients with trophoblastic tumour. Soma H, Kikuchi K, Takayama M, Saegusa H, Saito T, Kashiwagi H, Sayama S. Arch Gynecol; 1981 Jan 01; 230(4):321-7. PubMed ID: 6269502 [Abstract] [Full Text] [Related]
17. [The follow-up of trophoblastic disease by using an hCG-CTP enzyme immunoassay]. Matsuura Y, Kashimura M, Shinohara M, Baba S, Kondo M, Kashimura Y. Gan No Rinsho; 1990 Dec 01; 36(15):2559-62. PubMed ID: 2176247 [Abstract] [Full Text] [Related]
19. The utility of a rapid assay for human chorionic gonadotropin in the management of trophoblastic disease. Soules MR, Tyrey L, Hammond CB. Am J Obstet Gynecol; 1979 Oct 01; 135(3):384-92. PubMed ID: 225953 [Abstract] [Full Text] [Related]